Glipizide Therapy Monitoring.

A nurse is reviewing the laboratory results of a client who has diabetes mellitus and is taking glipizide.
Which of the following values indicates that the client is adhering to the treatment plan?

The correct answer is Choice C.

Choice A rationale:

• This response is not appropriate because it is judgmental and may make the client feel defensive.
• It is important for the nurse to respect the client's right to make their own decisions about their health care.
• Telling the client what they should do can undermine their autonomy and potentially damage the nurse-client relationship.
• It's crucial for the nurse to remain objective and avoid imposing their personal opinions or beliefs onto the client.

Choice B rationale:

• This response is also not appropriate because it is using scare tactics to try to persuade the client to get the vaccine.
• This approach can be counterproductive and may further alienate the client.
• It's important to provide accurate information about the risks and benefits of the vaccine in a neutral and non-threatening manner.

Choice C rationale:

• This is the most appropriate response because it acknowledges the client's right to refuse the vaccine while still encouraging them to get it.
• It also demonstrates respect for the client's autonomy and validates their feelings.
• This approach is more likely to foster a positive nurse-client relationship and keep the door open for future discussions about vaccination.

Choice D rationale:

• This response is not accurate because the influenza vaccine is not mandatory for all clients before discharge.
• It is important for the nurse to provide accurate information to the client.
• Threatening the client with an against medical advice form is not appropriate and may be considered a form of coercion.

The nurse should monitor the client for hearing loss because it is a potential adverse effect of erythromycin.

Choice B is wrong because a high-fiber diet to prevent constipation is not mentioned as a necessary action when administering erythromycin lactobionate IV bolus.

Choice C is wrong because erythromycin lactobionate IV bolus should not be administered over 10 min; bolus injection (IV push) is contraindicated.

Choice D is wrong because erythromycin lactobionate should not be reconstituted with a 5% dextrose solution; it should be reconstituted with sterile water for injection.